
RBC Capital Markets | Home
The most significant corporations, institutional investors, asset managers, private equity firms, and governments around the globe recognize RBC Capital Markets as an innovative, trusted partner with an in-depth expertise in capital markets, banking, and finance.
About Us - RBC Capital Markets
RBC Capital Markets is part of a leading provider of financial services, Royal Bank of Canada (RBC). Operating since 1869, RBC is one of the largest banks in the world and the fifth largest in North America, as measured by market capitalization.
RBC Capital Markets - Wikipedia
RBC Capital Markets is a global investment bank providing services in banking, finance, and capital markets to corporations, institutional investors, asset managers, and governments globally. Locations span 58 offices in 14 countries [1] across North America, the UK, Europe, and the Asia-Pacific region. Employment estimates for RBC ...
Our Offices - RBC Capital Markets
With 63 offices across 15 countries, RBC Capital Markets provides world-class banking, advisory, and capital markets services to clients worldwide. Our team of over 7,800 professionals collaborates across North America, Europe, and the Asia-Pacific region, delivering localized expertise with a global perspective.
RBC Capital Markets - LinkedIn
RBC Capital Markets is recognized by the most significant corporations, institutional investors, asset managers, private equity firms, and governments around the globe as an innovative, trusted...
RBC Capital Remains a Buy on Kelt Exploration (KELTF)
7 hours ago · RBC Capital analyst Michael Harvey maintained a Buy rating on Kelt Exploration (KELTF – Research Report) yesterday and set a price target of C$8.00. The company’s shares closed last Tuesday at ...
RBC Capital Remains a Buy on AtkinsRealis (SNCAF)
7 hours ago · RBC Capital analyst Sabahat Khan reiterated a Buy rating on AtkinsRealis (SNCAF – Research Report) today and set a price target of C$92.00. The company’s shares closed yesterday at $44.94.
RBC Capital Sticks to Their Buy Rating for Allogene Therapeutics …
8 hours ago · In a report released yesterday, Luca Issi from RBC Capital maintained a Buy rating on Allogene Therapeutics (ALLO – Research Report), with a price target of $10.00. The company’s shares closed ...
RBC Capital Initiates Coverage of Natera (NTRA) with Outperform …
1 day ago · Fintel reports that on March 13, 2025, RBC Capital initiated coverage of Natera (NasdaqGS:NTRA) with a Outperform recommendation. Analyst Price Forecast Suggests 36.88% Upside As of March 4, 2025 ...
RBC CM Online - RBC Capital Markets
© RBC Dominion Securities Inc. 2001, 2003, 2010 rbccm.com is an online information service operated by RBC Dominion Securities Inc. and the other businesses and legal entities …